A further understanding of the mechanism underlying the link between circulating FABP4 and cardiovascular events may enable the development of new therapeutic strategies for metabolic and cardiovascular diseases such as inhibition of FABP4, neutralization of FABP4 and blockade of the possible FABP4 receptor. Here, FABP4 is linked to cardiovascular disorder.